Literature DB >> 21880396

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers.

Diane Slats1, Jurgen A H R Claassen, Petra E Spies, George Borm, Kees T C Besse, William van Aalst, Jack Tseng, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbeek.   

Abstract

Large hour-to-hour variability has previously been demonstrated in the cerebrospinal fluid (CSF) concentrations of Alzheimer's disease (AD) biomarkers amyloid β(42) (Aβ(42)) and Aβ(40) in healthy younger subjects. We investigated the within-subject variability over 36 hours in CSF Aβ and tau proteins, in older subjects and AD patients. Six patients with mild stage AD (59-85 years, Mini Mental State Examination (MMSE) 16-26) and 6 healthy older volunteers (64-77 years) received an intrathecal catheter from which, during 36 hours, each hour 6 mL of CSF was drawn. Concentrations of Aβ(42), Aβ(40), total tau, and phosphorylated tau were determined and the variability was analyzed. Within-subject variability within 3-hour periods was assessed as the coefficient of variation, which was comparable for these 4 biomarkers in controls (4.2%-4.6%) and AD (3.1%-5.8%). Variability over 12 hour periods was 5.3% to 9.5%. These findings suggest that CSF biomarker variability is relatively low in healthy older controls and AD patients. Furthermore, continuous sampling of CSF proved to be a useful and robust method, which may also be used to investigate AD pathogenesis and to evaluate pharmacotherapeutic interventions. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880396     DOI: 10.1016/j.neurobiolaging.2011.07.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Serum tau concentration after diving - an observational pilot study.

Authors:  Anders Rosén; Nicklas Oscarsson; Andreas Kvarnström; Mikael Gennser; Göran Sandström; Kaj Blennow; Helen Seeman-Lodding; Henrik Zetterberg
Journal:  Diving Hyperb Med       Date:  2019-06-30       Impact factor: 0.887

2.  γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ.

Authors:  Fei Liu; Zhi-Qin Xue; Si-Hao Deng; Xiong Kun; Xue-Gang Luo; Peter R Patrylo; Gregory M Rose; Huaibin Cai; Robert G Struble; Yan Cai; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2013-02-22       Impact factor: 3.386

3.  Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuations.

Authors:  Marcel M Verbeek; Wilhelmina G Leen; Michèl A Willemsen; Diane Slats; Jurgen A Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

4.  Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption.

Authors:  Margaret S Blattner; Sunil K Panigrahi; Cristina D Toedebusch; Terry J Hicks; Jennifer S McLeland; Ian R Banks; Claire Schaibley; Vitaliy Ovod; Kwasi G Mawuenyega; Randall J Bateman; Sharon L Wardlaw; Brendan P Lucey
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Authors:  Khutso M Mothapo; J Ten Oever; P Koopmans; F F Stelma; S Burm; J Bajramovic; M M Verbeek; M G Olde Rikkert; M G Netea; G Koopman; A J van der Ven
Journal:  J Neurovirol       Date:  2016-11-23       Impact factor: 2.643

6.  Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile.

Authors:  Izaak den Daas; Johan Wemer; Khalid Abou Farha; Wim Tamminga; Theo de Boer; Rob Spanjersberg; Michel M R F Struys; Anthony R Absalom
Journal:  Eur J Clin Pharmacol       Date:  2012-11-10       Impact factor: 2.953

7.  Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.

Authors:  Brendan P Lucey; Kwasi G Mawuenyega; Bruce W Patterson; Donald L Elbert; Vitaliy Ovod; Tom Kasten; John C Morris; Randall J Bateman
Journal:  JAMA Neurol       Date:  2017-02-01       Impact factor: 18.302

8.  β-amyloid dynamics in human plasma.

Authors:  Yafei Huang; Rachel Potter; Wendy Sigurdson; Tom Kasten; Rose Connors; John C Morris; Tammie Benzinger; Mark Mintun; Tim Ashwood; Mats Ferm; Samantha L Budd; Randall J Bateman
Journal:  Arch Neurol       Date:  2012-12

9.  Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity.

Authors:  Rolf Anckarsäter; Henrik Anckarsäter; Sara Bromander; Kaj Blennow; Caroline Wass; Henrik Zetterberg
Journal:  J Neural Transm (Vienna)       Date:  2014-01-14       Impact factor: 3.575

Review 10.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.